News

Many thanks to our partners from Universitätsklinik Bonn, INSIGHTEC, and Fraunhofer MEVIS for a great collaboration in the concluded project tcFUScontrol funded by ZIM. We aimed at developing an Advanced Therapy Control System for transcranial MR-guided Focused Ultrasound for Essential and Parkinson’s Tremor.

The consortium made progress in using Arterial Spin Labeling (ASL) MR images to measure the permeability of the blood brain barrier (BBB). Apart from that, a software tool for easier therapy planning computing the location of nerve fibre tracks in the brain based on Diffusion Tensor Imaging was developed.

The countdown is on: The final year of our DeepRAY project has begun. Together with our partners at Universitätsmedizin Mannheim we are working to integrate our WHITEBOX into the clinical workflow of routine abdominal CT scans. We will screen the patients for aortic aneurysms and dissections with AI-based algorithms (what else?).

The WHITEBOX enables easy and secure DICOM image transfer between the PACS and external server clusters for fast image analyses and notification of clinical staff.

First milestones are achieved: the WHITEBOX is a PACS node of the research PACS and retrospective data analysis can be performed easily. Now we are aiming to install our system in the clinic PACS for prospective evaluations.

The project DeepRAY is funded by the German Ministry of Education and Research.

mediri wishes you merry christmas and a happy new year.

Mediri is constantly evolving its image data management platform mTRIAL for secure and reliable central reads in clinical studies. Currently, mTRIAL is getting ready for RANO evaluation of low- and high-grade gliomas. Automatic interpolation of segmented volumes and easy annotation of measurements are on board. Stay posted.

Recently, a newspaper article about our project BOSOMSHIELD got mentioned in the newspaper echo-online. If you want to know more about the importance of our work and how we want to improve the field of breast cancer, you can read the article down below. 

Today is International Day of Radiology to promote the seismic impact of radiology on medicine – earlier detection, fewer surgeries, and game-changing treatment outcomes. Analyzing radiological images in multi centric clinical studies can be challenging considering standardization and patient data privacy.
Mediri is constantly evolving its image data management platform mTRIAL for secure and reliable central reads in clinical studies. Currently, mTRIAL is getting ready for RANO 2.0 evaluation of low- and high-grade gliomas according to the recently published update by Wen et al. Stay posted.

RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults | Journal of Clinical Oncology (ascopubs.org)

New office. New Neighbours. New view.
It’s done! We have offically moved to Am Taubenfeld 21/1 in 69123 Heidelberg.

These numbers again stress the importance of research in breast cancer detection and relapse prediction. We are proud to be part of the Marie-Sklodowska Curie network bosomshield.eu aiming at the combination of clinical, pathological and radiological data for better treatment and therapies. Still, early detection of breast cancer is one of the most important factors for successfull treatment, so be mindful and take care of yourself!

Klinische Forschung neu denken: Vom Patienten bis zur KI.

World Alzheimer’s Day is a global effort to raise awareness and challenge the stigma around Alzheimer’s disease and other dementia. Do you know the differences between Alzheimer’s and dementia?
Dementia is a general term for a decline in mental ability severe enough to interfere with daily life. Alzheimer’s is one of several potential reasons for this decline, among them Frontotemporal Dementia, Huntington’s Disease, Parkinsons’s, or Vascular Dementia. Functional brain imaging is a cornerstone for the differentiation between all these different types of dementia and can support patient management as well as the research for potential therapies.
Perfusion imaging with Arterial Spin Labeling MRI has the potential to differentiate between Alzheimer’s and FTD but lacks standardization. In the ASPIRE project we develop an easy-to-use ASL evaluation tool that helps physicians to compare the brain perfusion pattern of a patient to a healthy control group. For more information visit aspire-mri.eu and alz.org.